Wild-type (senile) amyloidosis epidemiology and demographics: Difference between revisions
No edit summary |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Wild-type (senile) amyloidosis}} | {{Wild-type (senile) amyloidosis}} | ||
{{CMG}} | {{CMG}}{{AE}}{{Sab}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The actual [[incidence]] of wild-type (senile) amyloidosis in particular is unknown. | The [[incidence]] of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The actual [[incidence]] of wild-type (senile) amyloidosis in particular is unknown. The [[mortality rate]] of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries. [[Patient|Patients]] with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older). There is no racial predilection to wild-type (senile) amyloidosis. Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
| Line 16: | Line 16: | ||
* The [[prevalence]] of wild-type (senile) amyloidosis has not been determined. | * The [[prevalence]] of wild-type (senile) amyloidosis has not been determined. | ||
* It is estimated that approximately 25% of the people beyond the age of 80 have cardiac TTR deposition.<ref>{{Cite journal | |||
| author = [[G. G. 3rd Cornwell]], [[W. L. Murdoch]], [[R. A. Kyle]], [[P. Westermark]] & [[P. Pitkanen]] | |||
| title = Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation | |||
| journal = [[The American journal of medicine]] | |||
| volume = 75 | |||
| issue = 4 | |||
| pages = 618–623 | |||
| year = 1983 | |||
| month = October | |||
| doi = 10.1016/0002-9343(83)90443-6 | |||
| pmid = 6624768 | |||
}}</ref> | |||
=== Mortality rate === | === Mortality rate === | ||
| Line 31: | Line 43: | ||
=== Gender === | === Gender === | ||
* Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women. | * Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.<ref>{{Cite journal | ||
| author = [[Belinda Ng]], [[Lawreen H. Connors]], [[Ravin Davidoff]], [[Martha Skinner]] & [[Rodney H. Falk]] | |||
| title = Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis | |||
| journal = [[Archives of internal medicine]] | |||
| volume = 165 | |||
| issue = 12 | |||
| pages = 1425–1429 | |||
| year = 2005 | |||
| month = June | |||
| doi = 10.1001/archinte.165.12.1425 | |||
| pmid = 15983293 | |||
}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 18:31, 20 December 2019
|
Wild-type (senile) amyloidosis Microchapters |
|
Differentiating Wild-type (senile) amyloidosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wild-type (senile) amyloidosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis epidemiology and demographics |
|
FDA on Wild-type (senile) amyloidosis epidemiology and demographics |
|
CDC on Wild-type (senile) amyloidosis epidemiology and demographics |
|
Wild-type (senile) amyloidosis epidemiology and demographics in the news |
|
Blogs on Wild-type (senile) amyloidosis epidemiology and demographics |
|
Risk calculators and risk factors for Wild-type (senile) amyloidosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The actual incidence of wild-type (senile) amyloidosis in particular is unknown. The mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries. Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older). There is no racial predilection to wild-type (senile) amyloidosis. Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.
Epidemiology and Demographics
Incidence
- The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide.[1]
- The actual incidence of wild-type (senile) amyloidosis in particular is unknown.
Prevalence
- The prevalence of wild-type (senile) amyloidosis has not been determined.
- It is estimated that approximately 25% of the people beyond the age of 80 have cardiac TTR deposition.[2]
Mortality rate
- The mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries.[3]
Age
- Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older).
Race
- There is no racial predilection to wild-type (senile) amyloidosis.
Gender
- Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.[4]
References
- ↑ Khan MF, Falk RH (November 2001). "Amyloidosis". Postgrad Med J. 77 (913): 686–93. PMC 1742163. PMID 11677276.
- ↑ G. G. 3rd Cornwell, W. L. Murdoch, R. A. Kyle, P. Westermark & P. Pitkanen (1983). "Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation". The American journal of medicine. 75 (4): 618–623. doi:10.1016/0002-9343(83)90443-6. PMID 6624768. Unknown parameter
|month=ignored (help) - ↑ Pepys MB (2006). "Amyloidosis". Annu. Rev. Med. 57: 223–41. doi:10.1146/annurev.med.57.121304.131243. PMID 16409147.
- ↑ Belinda Ng, Lawreen H. Connors, Ravin Davidoff, Martha Skinner & Rodney H. Falk (2005). "Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis". Archives of internal medicine. 165 (12): 1425–1429. doi:10.1001/archinte.165.12.1425. PMID 15983293. Unknown parameter
|month=ignored (help)